Related references
Note: Only part of the references are listed.Alterations in Nucleolar Structure and Gene Expression Programs in Prostatic Neoplasia Are Driven by the MYC Oncogene
Cheryl M. Koh et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
Gottfried E. Konecny et al.
CLINICAL CANCER RESEARCH (2011)
Small-Cell Carcinoma of the Parotid Gland
Joanie M. Baca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo
Huifang Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
RB-pathway disruption in breast cancer Differential association with disease subtypes, disease-specific prognosis and therapeutic response
Adam Ertel et al.
CELL CYCLE (2010)
Targeting the RB-pathway in Cancer Therapy
Erik S. Knudsen et al.
CLINICAL CANCER RESEARCH (2010)
CDK Inhibitors: From the Bench to Clinical Trials
Flavio Rizzolio et al.
CURRENT DRUG TARGETS (2010)
The ups and downs of Myc biology
Laura Soucek et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Molecular genetics of prostate cancer: new prospects for old challenges
Michael M. Shen et al.
GENES & DEVELOPMENT (2010)
The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer?
Kay F. Macleod
JOURNAL OF CLINICAL INVESTIGATION (2010)
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
Ankur Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The E2F1/Rb and p53/MDM2 Pathways in DNA Repair and Apoptosis: Understanding the Crosstalk to Develop Novel Strategies for Prostate Cancer Radiotherapy
Thirupandiyur Udayakumar et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
Karen E. Knudsen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy
D. Trere et al.
ANNALS OF ONCOLOGY (2009)
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
Pernille Lassen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cell cycle kinases as therapeutic targets for cancer
Silvia Lapenna et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets
Bora Gurel et al.
ADVANCES IN ANATOMIC PATHOLOGY (2008)
Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo
Kathleen F. Pirollo et al.
CLINICAL CANCER RESEARCH (2008)
Phase III Trial of Androgen Ablation With or Without Three Cycles of Systemic Chemotherapy for Advanced Prostate Cancer
Randall E. Millikan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tailoring to RB: tumour suppressor status and therapeutic response
Erik S. Knudsen et al.
NATURE REVIEWS CANCER (2008)
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Deborah L. Burkhart et al.
NATURE REVIEWS CANCER (2008)
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
Jason I. Herschkowitz et al.
BREAST CANCER RESEARCH (2008)
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function
M. P. Markey et al.
ONCOGENE (2007)
Prognostic value of p16 in locally advanced prostate cancer: A study based on Radiation Therapy Oncology Group protocol 9202
Arnab Chakravarti et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells
Ankur Sharma et al.
CANCER RESEARCH (2007)
Priorities in colorectal cancer research: Recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups
Peter J. O'Dwyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cell cycle kinases in cancer
Marcos Malumbres et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Emily E. Bosco et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Retinoblastoma deficiency increases chemosensitivity in lung cancer
William A. Zagorski et al.
CANCER RESEARCH (2007)
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)
Maha Hussain et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis
SJ Libertini et al.
PROSTATE (2006)
Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model
R Hill et al.
CANCER RESEARCH (2005)
Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee
SB Shappell et al.
CANCER RESEARCH (2004)
Conditional deletion of Rb causes early stage prostate cancer
LA Maddison et al.
CANCER RESEARCH (2004)
Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: An analysis from the Radiation Therapy Oncology Group protocol 86-10
A Chakravarti et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis
KC Day et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate
CN Papandreou et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
RB-dependent S-phase response to DNA damage
KE Knudsen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
